Additives gear up.(Detergents 97)

From: Chemical Market Reporter | Date: January 27, 1997| Author: Van Arnum, Patricia | Copyright information

Detergent producers are increasingly seeking additives that enhance performance but are cost effective. Enzymes and detergent polymers fit that description. The estimated market for detergent enzymes, not counting detergent makers' captive production, is $400 million, according to Novo Nordisk's Robert J. Petrowski. Novo and Genencor International are the leading detergent enzymes producers. An overview of the detergent additives market is presented.

Detergent additives are meeting...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

NOVO NORDISK TO END 2 DRUG PARTNERSHIPS WITH SPINOFF ZYMOGENETICS DOWNPLAYS MOVE.(Business)
Seattle Post-Intelligencer (Seattle, WA) ; Byline: JOSEPH TARTAKOFF P-I reporter Novo Nordisk, the Danish health care company that spun off ZymoGenetics eight years ago, plans to pull out of two partnerships to develop drugs with the Seattle company - moves that ZymoGenetics downplayed but that one analyst said raised questions about the
Novo Nordisk: the bricks and mortar of diabetes care.(Brief Article)
Journal of Diabetes Nursing ; Novo Nordisk injection devices and needles have achieved a reputation of being the bricks and mortar of diabetes care. Novo Nordisk have chosen reliability as the flag to bring home for people with diabetes throughout the UK, Europe and further afield. Insulin saves lives every day, and the
NOVO NORDISK PUBLISHES THIRD ENVIRONMENTAL REPORT
Industrial Environment ; For a third successive year Danish-based Novo Nordisk has published its Environmental Report which reviews the Group's environmental performance in 1995 and sets targets for the future. Environmental targets reached by Novo Nordisk in 1995 include the following: A 12% increase in water
Novo Nordisk (China) Biotech Development Center Established in Beijing
China Chemical Reporter ; Novo Nordisk (China) Investment Co., Ltd. has recently an nounced the establishment of Novo Nordisk (China) Biotech Development Center in Beijing. The center has an investment of 1O million U.S. dollars. Our goal is to enable our products to occupy a favorable position in the Chinese market and the
FDA grants new indication to Novo Nordisk's NovoLog.(Focus)
Chain Drug Review ; PRINCETON, N.J. -- The Food and Drug Administration has approved NovoLog insulin aspart (rDNA-origin) injection for the treatment of diabetes in children. The rapid-acting insulin analog, which can be administered immediately before a meal, is considered an effective treatment for a growing patient
INNATE PHARMA AND NOVO NORDISK A/S PARTNERSHIP REFOCUSED ON THE INFLAMMATORY FIELD Conference Call - Final
Fair Disclosure Wire ; ... Novo Nordisk this [repercussion] -- this news about the repercussion of oncology on Wednesday ... evening, so this is obviously a very fresh news. We are certainly a bit disappointed not ... provided, however, that members of the news media may redistribute limited portions ...
Pfizer Inc. (Active Pharmaceutical Ingredient Watch).(seeks to terminate license agreement with Novo Nordisk )(Brief Article)
Chemical Market Reporter ; NOVO NORDISK A/S reports that Pfizer Inc. has attempted to terminate the license agreement under which Pfizer markets Novo Nordisk's portfolio of hormone replacement therapy products, Activella and Vagifem, in the US. In 2002, Novo Nordisk gained a licensing payment of roughly DKK100 million ($16
Novo Nordisk to Utilize Aris Global's Software Solutions for Regulatory Information Management.
Health & Beauty Close-Up ; HEALTH AND BEAUTY CLOSE-UP-29 June 2008-Novo Nordisk to Utilize Aris Global's Software Solutions for Regulatory Information Management(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Aris Global, a provider of software solutions for the life sciences industry, recently announced that Novo
Novo Nordisk.(MANUFACTURERS)(Howard Levy appointed at Novo Nordisk)(Brief article)
Medical Marketing & Media ; Novo Nordisk has announced the appointment of Howard Levy, M.D., PhD, as executive director of clinical research-hemostasis in the company's clinical development, medical and regulatory affairs department, and the appointment of Henry Cortina as associate VP of information technology in the United
Novo Nordisk runs consumer education promotion. (Novo Nordisk Pharmaceuticals Inc.)
Chain Drug Review ; PRINCETON, N.JNovo Nordisk Pharmaceuticals Inc. is running a consumer education promotion with drug chains that the insulin manufacturer says builds store loyalty. The promotion, Keeping Well with Diabetes, features a counter display explaining the campaign to consumers. Consumers who sign up